FDMT — 4D Molecular Therapeutics, Inc. stock price, charts and financials

QT694D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
15.22
+0.54+3.68%
OverviewShort InterestFilings
FDMTQT694D Molecular Therapeutics, Inc.·NASDAQ
15.22+3.68%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 16, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 21, 20264Statement of changes in beneficial ownership
Aug 17, 20264Statement of changes in beneficial ownership
Aug 13, 20268-KCurrent report
Aug 13, 202610-QQuarterly report
Aug 05, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Jul 20, 20268-KCurrent report
Jul 14, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 25, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 22, 20268-KCurrent report
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
#1 / 25 of 323
Page
▼
/ 13